RNA extraction machine market seen reaching $2.27 billion by 2030

The RNA extraction machine market is projected to grow from $1.34 billion in 2025 to $2.27 billion by 2030, driven by molecular diagnostics, genomic research and demand for automated sample prep. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - RNA extraction machines support clinical testing and research by isolating and purifying RNA for molecular analysis. - Demand is rising as diagnostics, genomics and precision medicine rely more heavily on accurate RNA preparation. - The market’s growth reflects broader pressure for faster, more standardized and more automated lab workflows.

What happened: - The Business Research Company said the RNA extraction machine market will rise from $1.34 billion in 2025 to $1.5 billion in 2026. - The report projects the market will reach $2.27 billion by 2030. - The forecast implies a 2025-2026 CAGR of 11.3% and a 2026-2030 CAGR of 10.9%. - The report was published Sept. 22, 2026, from London.

The details: - RNA extraction machines are automated tools used to isolate and purify RNA from biological specimens. - The machines use specialized reagents and extraction techniques to produce high-quality RNA. - They are designed to improve reliability, consistency and efficiency in RNA preparation. - Historical growth was driven by molecular diagnostics in clinical labs, genomic and transcriptomic research, infectious and genetic disease burden, R&D spending in pharma and biotech, and standardized automated extraction workflows. - Future growth is expected to come from personalized healthcare, precision medicine, next-generation sequencing, automation in sample preparation, decentralized and point-of-care diagnostics, and stronger biotech infrastructure. - Infectious disease demand remains a key driver because automated RNA isolation supports high-throughput processing and precise molecular testing. - England reported 630 laboratory-confirmed measles cases between Jan. 1 and May 25, 2026, underscoring the need for efficient diagnostic tools. - Personalized medicine is also boosting demand because RNA extraction supports gene expression studies, biomarker discovery and treatment customization. - The FDA approved 16 new personalized treatments for rare diseases in 2023, up from six in 2022. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

Between the lines: - The forecast suggests RNA extraction equipment is becoming a core pick-and-shovel market for precision medicine and molecular diagnostics. - The regional split points to an established market in North America and newer growth opportunities in Asia-Pacific. - The report’s emphasis on automation suggests buyers are prioritizing throughput, consistency and lower manual handling over standalone lab equipment.

What's next: - The market is likely to benefit from broader use of next-generation sequencing and point-of-care diagnostics. - Suppliers may compete more on workflow automation, scalability and integration with genomic testing platforms. - Expanded biotech infrastructure and personalized medicine adoption could sustain demand through 2030.

The bottom line: - RNA extraction machines are moving from niche lab tools to infrastructure for modern molecular diagnostics, with global demand on track to nearly double by 2030.